Medical Articles

Pamidronate

Drugs used in osteoporosis acting on bone metabolism

Description

Pamidronate is a medication used in the management and treatment of moderate or severe hypercalcemia of malignancy, moderate to severe Paget disease of bone, osteolytic bone metastases of breast cancer, and osteolytic lesions of multiple myeloma. It is in the bisphosphonate class of medications.

Mechanism of action

The mechanism of antiresorptive action of pamidronate is not well understood. Several factors are thought to contribute to this action. Pamidronate adsorbs to calcium phosphate (hydroxy-apatite) crystals in bone and may directly block dissolution of this mineral component of bone. Inhibition of osteoclast activity also contributes to inhibition of bone resorption. Pamidronate inhibits the accelerated bone resorption resulting from osteoclast hyperactivity induced by various tumours and this is of significance in treatment of malignancy induced hyper-calcaemia.

This page is restricted. Please Login / Register to view this page.

Mechanism of action

The mechanism of antiresorptive action of pamidronate is not well understood. Several factors are thought to contribute to this action. Pamidronate adsorbs to calcium phosphate (hydroxy-apatite) crystals in bone and may directly block dissolution of this mineral component of bone. Inhibition of osteoclast activity also contributes to inhibition of bone resorption. Pamidronate inhibits the accelerated bone resorption resulting from osteoclast hyperactivity induced by various tumours and this is of significance in treatment of malignancy induced hyper-calcaemia.

This page is restricted. Please Login / Register to view this page.